Organoid: Bridging the gap between basic research and clinical practice.

[1]  J. Gartner,et al.  Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens , 2023, Cancer Immunology, Immunotherapy.

[2]  Jiaxi Tang,et al.  Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice , 2023, Cancer Cell International.

[3]  Jung Won Chun,et al.  Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients. , 2023, Cancer research and treatment.

[4]  M. Opyrchal,et al.  A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy , 2023, Advanced science.

[5]  R. Kurzrock,et al.  ExoLuminate: An observational registry study for detection of pancreatic adenocarcinoma (PDAC) in high-risk or clinically suspicious patients. , 2023, Journal of Clinical Oncology.

[6]  L. Tiberi,et al.  Medulloblastoma and high-grade glioma organoids for drug screening, lineage tracing, co-culture and in vivo assay , 2023, Nature Protocols.

[7]  A. Carrato,et al.  Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue. , 2023, Journal of Visualized Experiments.

[8]  Y. Dou,et al.  Modeling kidney development, disease, and plasticity with clonal expandable nephron progenitor cells and nephron organoids , 2023, bioRxiv.

[9]  Jianguo Wu,et al.  SARS-CoV-2 N protein enhances the anti-apoptotic activity of MCL-1 to promote viral replication , 2023, Signal transduction and targeted therapy.

[10]  Haojia Wu,et al.  A single-cell multiomic analysis of kidney organoid differentiation , 2023, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Sean R. Collins,et al.  Vangl-dependent Wnt/planar cell polarity signaling mediates collective breast carcinoma motility and distant metastasis , 2023, Breast Cancer Research.

[12]  J. Lindebjerg,et al.  Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study , 2023, Journal of Experimental & Clinical Cancer Research.

[13]  J. Shrager,et al.  Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection , 2023, Research square.

[14]  S. Kaur,et al.  Liver organoids as a primary human model to study HBV-mediated Hepatocellular carcinoma. A review. , 2023, Experimental cell research.

[15]  S. Blackshaw,et al.  Single-cell transcriptome analysis of xenotransplanted human retinal organoids defines two migratory cell populations of nonretinal origin , 2023, Stem cell reports.

[16]  K. Wennerberg,et al.  A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids , 2023, Developmental cell.

[17]  Bas B L Penning de Vries,et al.  Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification. , 2023, Med.

[18]  J. Ku,et al.  Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Pancreatic Cancer Cells , 2023, Cancers.

[19]  R. Dienstmann,et al.  Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer , 2023, ESMO open.

[20]  J. Quintana,et al.  Modelling host- Trypanosoma brucei gambiense interactions in vitro using human induced pluripotent stem cell-derived cortical brain organoids , 2023, F1000Research.

[21]  Jing-ming Lu,et al.  Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors , 2023, Frontiers in Cell and Developmental Biology.

[22]  Matthew V. Holt,et al.  Abstract LB134: Targeting coactivators to inhibit ESR1 fusion-driven breast cancer growth , 2023, Cancer Research.

[23]  A. Hsieh,et al.  Combinatorial genetic strategy accelerates the discovery of cancer genotype-phenotype associations , 2023, bioRxiv.

[24]  Hao Zhang,et al.  Patient-derived xenograft models in cancer therapy: technologies and applications , 2023, Signal Transduction and Targeted Therapy.

[25]  M. Roussel,et al.  Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities , 2023, Oncogene.

[26]  M. Putker,et al.  Abstract 198: Pan-cancer assay-ready organoid drug screening with robust, reproducible and clinically-relevant output , 2023, Cancer Research.

[27]  A. Oberg,et al.  Abstract 4724: Single cell multiomic profiling of high-grade serous carcinoma , 2023, Cancer Research.

[28]  Riajul Wahab,et al.  Abstract 156: An ascitic fluid-derived organoid platform for Hispanic ovarian cancer patients to capture heterogeneity and disparity , 2023, Cancer Research.

[29]  F. Pourfarzad,et al.  Abstract 908: Tumour organoid-t cell co-culture assay to evaluate CAR t cell cytotoxicity , 2023, Cancer Research.

[30]  Yingyan Yu,et al.  Patient-derived organoids in translational oncology and drug screening. , 2023, Cancer letters.

[31]  M. Hsiao,et al.  Independent Signaling of Hepatoma Derived Growth Factor and Tumor Necrosis Factor-Alpha in Human Gastric Cancer Organoids Infected by Helicobacter pylori , 2023, International journal of molecular sciences.

[32]  S. Louis,et al.  Primary human-derived airway organoid and immune cell co-cultures to facilitate viral infection and drug screening assays , 2023, 03.02 - Airway cell biology and immunopathology.

[33]  Todd A. Johnson,et al.  Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma. , 2023, Cell reports.

[34]  S. Cho,et al.  Refining classification of cholangiocarcinoma subtypes via proteogenomic integration reveals new therapeutic prospects. , 2023, Gastroenterology.

[35]  E. Petricoin,et al.  Abstract PD5-02: PD5-02 An Organoid Model System to Study Resistance Mechanisms, Predictive Biomarkers, and New Strategies to Overcome Therapeutic Resistance in Early-Stage Triple-Negative Breast Cancer , 2023, Cancer Research.

[36]  Laura F. Dagley,et al.  S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer , 2023, Cell Death & Differentiation.

[37]  T. Noda,et al.  Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin , 2023, Breast Cancer Research.

[38]  A. Cambi,et al.  Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids , 2023, Frontiers in Immunology.

[39]  Qionglin Liang,et al.  Organoids/organs-on-a-chip: new frontiers of intestinal pathophysiological models. , 2023, Lab on a chip.

[40]  Zhaoxiang Bian,et al.  Gut microbiota and colorectal cancer metastasis. , 2022, Cancer letters.

[41]  S. Welch,et al.  Abstract B029: Epigenetic characterization of patient-derived organoids and cancer-associated fibroblasts from endoscopic ultrasound of pancreatic cancer , 2022, Cancer Research.

[42]  S. Achilefu,et al.  Breast cancer mutations HER2V777L and PIK3CAH1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance , 2022, bioRxiv.

[43]  Seyed Abbas Mirzaei,et al.  CRISPR/Cas9 as precision and high-throughput genetic engineering tools in gastrointestinal cancer research and therapy. , 2022, International journal of biological macromolecules.

[44]  Xuelu Zhang,et al.  OrganoidDB: a comprehensive organoid database for the multi-perspective exploration of bulk and single-cell transcriptomic profiles of organoids , 2022, Nucleic Acids Res..

[45]  H. Horlings,et al.  2022-RA-953-ESGO Serine metabolism remodeling after platinum-based chemotherapy is a new vulnerability in resistant ovarian cancer patients , 2022, Ovarian cancer.

[46]  M. Lazar,et al.  Modelling metabolic diseases and drug response using stem cells and organoids , 2022, Nature Reviews Endocrinology.

[47]  G. Wang,et al.  Mitochondrial fragmentation in liver cancer: Emerging player and promising therapeutic opportunities. , 2022, Cancer letters.

[48]  Wei Xue,et al.  Prostate cancer treatment - China's perspective. , 2022, Cancer letters.

[49]  J. Ferlay,et al.  Global burden of primary liver cancer in 2020 and predictions to 2040 , 2022, Journal of hepatology.

[50]  Juergen A. Knoblich,et al.  Human organoids: New strategies and methods for analyzing human development and disease , 2022, Cell.

[51]  Z. Cai,et al.  Patient‐derived renal cell carcinoma organoids for personalized cancer therapy , 2022, Clinical and translational medicine.

[52]  J. M. Crawford,et al.  Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy , 2022, Annals of surgery.

[53]  Richard S. Kwon,et al.  The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  S. Soker,et al.  Abstract 3076: Low PTIP expression is linked to HIPEC resistance in appendiceal cancer , 2022, Cancer Research.

[55]  Xia Wang,et al.  Colorectal Cancer Patient‐Derived 2D and 3D Models Efficiently Recapitulate Inter‐ and Intratumoral Heterogeneity , 2022, Advanced science.

[56]  K. Chin,et al.  Modeling prostate cancer: What does it take to build an ideal tumor model? , 2022, Cancer letters.

[57]  S. Meltzer,et al.  Novel tumorigenic FOXM1-PTAFR-PTAF axis revealed by multi-omic profiling in TP53/CDKN2A-double knockout human gastroesophageal junction organoid model , 2022, bioRxiv.

[58]  E. Hatano,et al.  Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer , 2022, BMC cancer.

[59]  Lei Du,et al.  LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis. , 2022, Cancer letters.

[60]  Q. Ouyang,et al.  Helicobacter pylori infection induces stem cell-like properties in Correa cascade of gastric cancer. , 2022, Cancer letters.

[61]  M. Höglund,et al.  Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review , 2022, Cancers.

[62]  P. Boutros,et al.  Drug screening at single-organoid resolution via bioprinting and interferometry , 2021, bioRxiv.

[63]  G. Koifman,et al.  USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer , 2022, Nature Communications.

[64]  D. Aust,et al.  Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment , 2022, The Journal of pathology.

[65]  Xia Li,et al.  JAK-STAT1 Signaling Pathway Is an Early Response to Helicobacter pylori Infection and Contributes to Immune Escape and Gastric Carcinogenesis , 2022, International journal of molecular sciences.

[66]  E. Jaffee,et al.  Precision medicine in pancreatic cancer: Patient derived organoid pharmacotyping is a predictive biomarker of clinical treatment response. , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

[67]  J Zhang,et al.  Organoids in recapitulating tumorigenesis driven by risk factors: Current trends and future perspectives , 2022, International journal of biological sciences.

[68]  V. Puduvalli,et al.  Modeling of Aryl Hydrocarbon Receptor Pathway Intrinsic Immunometabolic Role using Glioblastoma Stem Cells and Patient-Derived Organoids , 2022, bioRxiv.

[69]  J. Kratz,et al.  Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids. , 2022, Annual review of biomedical engineering.

[70]  M. Cooperberg,et al.  Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states , 2022, Nature Communications.

[71]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[72]  J. Vinjé,et al.  Advances in understanding of the innate immune response to human norovirus infection using organoid models. , 2022, The Journal of general virology.

[73]  Wei Wei,et al.  Long noncoding RNA Meg3 sponges miR-708 to inhibit intestinal tumorigenesis via SOCS3-repressed cancer stem cells growth , 2021, Cell Death & Disease.

[74]  J. Iovanna,et al.  Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer , 2021, Translational oncology.

[75]  Xinhua Lin,et al.  Modeling hepatoblastoma development with human fetal liver organoids reveals YAP1 activation is sufficient for tumorigenesis , 2021, Protein & Cell.

[76]  R. Jenkins,et al.  Going with the Flow: Modeling the Tumor Microenvironment Using Microfluidic Technology , 2021, Cancers.

[77]  Á. Ayuso-Sacido,et al.  Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing. , 2021, Cancer letters.

[78]  L. Bertassoni.  Bioprinting of Complex Multicellular Organs with Advanced Functionality—Recent Progress and Challenges Ahead , 2021, Advanced materials.

[79]  Xinxiang Li,et al.  Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids , 2021, Journal of experimental & clinical cancer research : CR.

[80]  K. Konstantopoulos,et al.  Giant obscurin regulates migration and metastasis via RhoA-dependent cytoskeletal remodeling in pancreatic cancer. , 2021, Cancer letters.

[81]  Bangmao Wang,et al.  Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation? , 2021, Cancer letters.

[82]  Y. Qiao,et al.  Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries. , 2021, Cancer letters.

[83]  Ugljesa Djuric,et al.  The promise of organoids for unraveling the proteomic landscape of the developing human brain , 2021, Molecular Psychiatry.

[84]  M. Stoffel,et al.  miR-802 Suppress Acinar-to-Ductal Reprogramming during Early Pancreatitis and Pancreatic Carcinogenesis. , 2021, Gastroenterology.

[85]  Xi Chen,et al.  A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer , 2021, Molecular Cancer.

[86]  E. Dalla,et al.  Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN , 2021, Journal of experimental & clinical cancer research : CR.

[87]  H. Clevers,et al.  Organoids and organs-on-chips: Insights into human gut-microbe interactions. , 2021, Cell host & microbe.

[88]  Jun Won Park,et al.  In vivo CRISPR–Cas9 knockout screening using quantitative PCR identifies thymosin beta‐4 X‐linked that promotes diffuse‐type gastric cancer metastasis , 2021, Molecular carcinogenesis.

[89]  Ping Chen,et al.  Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics , 2021, Nature Communications.

[90]  H. Kestler,et al.  A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response , 2021, Zeitschrift für Gastroenterologie.

[91]  W. de Lau,et al.  A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses , 2021, Nature Communications.

[92]  F. Giorgino,et al.  Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper , 2021, ESMO open.

[93]  Xiaoya Zhao,et al.  Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer , 2021, Frontiers in Cell and Developmental Biology.

[94]  G. Garnier,et al.  A thermo-responsive collagen-nanocellulose hydrogel for the growth of intestinal organoids. , 2021, Materials science & engineering. C, Materials for biological applications.

[95]  E. Cuppen,et al.  Prospective experimental treatment of colorectal cancer patients based on organoid drug responses , 2021, ESMO open.

[96]  L. Matrisian,et al.  Estimated Projection of US Cancer Incidence and Death to 2040 , 2021, JAMA network open.

[97]  R. Wu,et al.  Single‐Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids , 2021, Advanced science.

[98]  M. Ferrer,et al.  Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer , 2021, Oncogene.

[99]  C. Leonetti,et al.  FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma. , 2021, Journal of hepatology.

[100]  J. G. van den Berg,et al.  Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma , 2021, Frontiers in Endocrinology.

[101]  Tao Xu,et al.  Islet organoid as a promising model for diabetes , 2021, Protein & Cell.

[102]  T. Mahmoudi,et al.  3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis. , 2021, Cancer letters.

[103]  David C. Smith,et al.  Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors , 2021, JAMA oncology.

[104]  Yuebang Yin,et al.  Single-Cell Sequencing and Organoids: A Powerful Combination for Modelling Organ Development and Diseases. , 2021, Reviews of physiology, biochemistry and pharmacology.

[105]  A. Stenzinger,et al.  SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas , 2021, Nature Metabolism.

[106]  M. Cattaneo,et al.  Multicellular 3D Models to Study Tumour-Stroma Interactions , 2021, International journal of molecular sciences.

[107]  N. Barker,et al.  A genome-scale CRISPR screen reveals factors regulating Wnt-dependent renewal of mouse gastric epithelial cells , 2021, Proceedings of the National Academy of Sciences.

[108]  Qi Cui,et al.  ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response , 2021, Cell Stem Cell.

[109]  S. Menini,et al.  Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress , 2021, Cancers.

[110]  M. Rivera,et al.  The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependencies , 2020, Life Science Alliance.

[111]  H. Clevers,et al.  SIRT1 inhibitors mitigate radiation-induced GI syndrome by enhancing intestinal-stem-cell survival. , 2020, Cancer letters.

[112]  Linda S. Lee,et al.  Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection. , 2020, Gastroenterology.

[113]  Yu Zhu,et al.  An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity , 2020, Cell reports. Medicine.

[114]  U. Hofmann,et al.  Metabolic Drug Response Phenotyping in Colorectal Cancer Organoids by LC-QTOF-MS , 2020, Metabolites.

[115]  M. Pirooznia,et al.  Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones , 2020, Genes.

[116]  Marcel A. Heinrich,et al.  3D In Vitro Model (R)evolution: Unveiling Tumor-Stroma Interactions. , 2020, Trends in cancer.

[117]  Soon Sung Kwon,et al.  Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells. , 2020, Cancer letters.

[118]  H. Clevers,et al.  CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids. , 2020, Cell stem cell.

[119]  M. Shahhoseini,et al.  Insight into epigenetics of human endometriosis organoids: DNA methylation analysis of HOX genes and their cofactors. , 2020, Fertility and sterility.

[120]  X. Lao,et al.  Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer. , 2020, Gastroenterology.

[121]  Meng Li,et al.  Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance , 2020, Cellular and molecular gastroenterology and hepatology.

[122]  H. de Reuse,et al.  Review: Pathogenesis of Helicobacter pylori infection , 2020, Helicobacter.

[123]  Min-Sik Kim,et al.  Mass spectrometry-based proteomics of single cells and organoids: The new generation of cancer research , 2020 .

[124]  C. Conrad,et al.  Single-cell analysis of patient-derived PDAC organoids reveals cell state heterogeneity and a conserved developmental hierarchy , 2020, Nature Communications.

[125]  Toshiro Sato,et al.  Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases , 2020, Nature Materials.

[126]  Jeffrey R. Millman,et al.  Single-Cell Transcriptome Profiling Reveals β Cell Maturation in Stem Cell-Derived Islets after Transplantation , 2020, Cell reports.

[127]  C. Kuo,et al.  Organoid Models of Tumor Immunology , 2020, Trends in immunology.

[128]  M. Kampmann.  CRISPR-based functional genomics for neurological disease , 2020, Nature Reviews Neurology.

[129]  S. Takayama,et al.  Cancer Cell Invasion of Mammary Organoids with Basal‐In Phenotype , 2020, Advanced healthcare materials.

[130]  Y. Arsenijévic,et al.  Hydrogel-based milliwell arrays for standardized and scalable retinal organoid cultures , 2020, Scientific Reports.

[131]  K. Anseth,et al.  The Effect of Thiol Structure on Allyl Sulfide Photodegradable Hydrogels and their Application as a Degradable Scaffold for Organoid Passaging , 2020, Advanced materials.

[132]  A. Muotri,et al.  Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions , 2020, Cell Research.

[133]  R. Evans,et al.  Immune evasive human islet-like organoids ameliorate diabetes , 2020, Nature.

[134]  L. Wood,et al.  Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome , 2020, Cancer Research.

[135]  E. Cuppen,et al.  Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine. , 2020, Cell reports.

[136]  M. Boutros,et al.  Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids. , 2020, Cell stem cell.

[137]  R. Palmqvist,et al.  Ex Vivo Organoid Cultures Reveal the Importance of the Tumor Microenvironment for Maintenance of Colorectal Cancer Stem Cells , 2020, Cancers.

[138]  M. Rubin,et al.  Patient-derived xenografts and organoids model therapy response in prostate cancer , 2020, Nature Communications.

[139]  P. Kemmeren,et al.  An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity , 2020, Nature Communications.

[140]  H. Clevers,et al.  Long-Term Expansion of Pancreatic Islet Organoids from Resident Procr+ Progenitors , 2020, Cell.

[141]  S. Butz,et al.  Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-β Resistance. , 2020, Cell stem cell.

[142]  Cole Trapnell,et al.  Single-Cell Transcriptomic Comparison of Human Fetal Retina, hPSC-Derived Retinal Organoids, and Long-Term Retinal Cultures , 2020, Cell reports.

[143]  H. Putter,et al.  Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis , 2020, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[144]  M. Tartaglia,et al.  Modeling medulloblastoma in vivo and with human cerebellar organoids , 2020, Nature Communications.

[145]  S. Batra,et al.  Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning , 2020, Clinical Cancer Research.

[146]  Xin Lu,et al.  CagA–ASPP2 complex mediates loss of cell polarity and favors H. pylori colonization of human gastric organoids , 2020, Proceedings of the National Academy of Sciences.

[147]  G. J. Yoshida.  Applications of patient-derived tumor xenograft models and tumor organoids , 2020, Journal of Hematology & Oncology.

[148]  M. Elbadawy,et al.  Patient-derived organoid analysis of drug resistance in precision medicine: is there a value? , 2020 .

[149]  B. Finlay,et al.  Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents , 2020, Cell.

[150]  S. Preissl,et al.  Single-cell multimodal omics: the power of many , 2020, Nature Methods.

[151]  H. Clevers,et al.  Organoids in immunological research , 2019, Nature Reviews Immunology.

[152]  R. Maizels,et al.  Organoids – New Models for Host–Helminth Interactions , 2019, Trends in Parasitology.

[153]  Max A. Horlbeck,et al.  CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma , 2019, Genome Biology.

[154]  Wen-Jeng Wu,et al.  Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis , 2019, Oncogene.

[155]  M. Meyerson,et al.  Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening , 2019, Nature Communications.

[156]  Peter A Mollica,et al.  3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels. , 2019, Acta biomaterialia.

[157]  J. Torresi,et al.  HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models , 2019, BMC Cancer.

[158]  H. Clevers,et al.  Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids. , 2019, Cell stem cell.

[159]  Hans Clevers,et al.  Cancer modeling meets human organoid technology , 2019, Science.

[160]  Xingyu Jiang,et al.  Cell-Based Assays on Microfluidics for Drug Screening. , 2019, ACS sensors.

[161]  Seok Chung,et al.  Clonorchis sinensis excretory-secretory products increase malignant characteristics of cholangiocarcinoma cells in three-dimensional co-culture with biliary ductal plates , 2019, PLoS pathogens.

[162]  Jiansong Ji,et al.  CRISPR-Cas9 for cancer therapy: Opportunities and challenges. , 2019, Cancer letters.

[163]  S. Rudzki,et al.  Environmental risk factors for cancer - review paper. , 2019, Annals of agricultural and environmental medicine : AAEM.

[164]  Wenwen Chen,et al.  Engineering human islet organoids from iPSCs using an organ-on-chip platform. , 2019, Lab on a chip.

[165]  T. Mahmoudi,et al.  Human liver organoids; a patient-derived primary model for HBV Infection and Related Hepatocellular Carcinoma , 2019, bioRxiv.

[166]  Q. Fang,et al.  Nanoliter Quantitative High-Throughput Screening with Large-Scale Tunable Gradients Based on a Microfluidic Droplet Robot under Unilateral Dispersion Mode. , 2019, Analytical chemistry.

[167]  R. Peek,et al.  Increased Programmed Death-Ligand 1 is an Early Epithelial Cell Response to Helicobacter pylori Infection , 2019, PLoS pathogens.

[168]  Matthias P Lutolf,et al.  Progress and potential in organoid research , 2018, Nature Reviews Genetics.

[169]  Taraka Sai Pavan Grandhi,et al.  3D heterogeneous islet organoid generation from human embryonic stem cells using a novel engineered hydrogel platform. , 2018, Biomaterials.

[170]  C. Winkler,et al.  Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma , 2018, Front. Genet..

[171]  Julio Saez-Rodriguez,et al.  A microfluidics platform for combinatorial drug screening on cancer biopsies , 2018, Nature Communications.

[172]  Robert E Denroche,et al.  Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. , 2018, Cancer discovery.

[173]  M. Estes,et al.  Differential expression of PD-L1 and Th1 response of lymphocytes co-cultured with human gastric organoids infected with Helicobacter pylori strains isolates from different gastric pathologies , 2018, Journal of Immunology.

[174]  Andrea Sottoriva,et al.  Patient-derived organoids model treatment response of metastatic gastrointestinal cancers , 2018, Science.

[175]  B. Poch,et al.  New Onset of Diabetes and Pancreatic Exocrine Insufficiency After Pancreaticoduodenectomy for Benign and Malignant Tumors: A Systematic Review and Meta-analysis of Long-term Results , 2018, Annals of surgery.

[176]  Xianjun Yu,et al.  Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis , 2017, Journal of Cancer.

[177]  Bin Tean Teh,et al.  Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. , 2017, Cancer discovery.

[178]  Arlene Weintraub.  All eyes on zebrafish , 2017, Lab Animal.

[179]  J. Bagley,et al.  Fused cerebral organoids model interactions between brain regions , 2017, Nature Methods.

[180]  Daniel R. Berger,et al.  Cell diversity and network dynamics in photosensitive human brain organoids , 2017, Nature.

[181]  Elijah Dixon,et al.  Epidemiology and risk factors: intrahepatic cholangiocarcinoma. , 2017, Hepatobiliary surgery and nutrition.

[182]  Hans Clevers,et al.  Modeling Development and Disease with Organoids , 2016, Cell.

[183]  S. Lopes,et al.  Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis , 2015, Nature.

[184]  H. Chan,et al.  Hepatitis B virus infection , 2014, The Lancet.

[185]  Norbert Perrimon,et al.  RNAi screening comes of age: improved techniques and complementary approaches , 2014, Nature Reviews Molecular Cell Biology.

[186]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. , 2012, The Lancet. Oncology.

[187]  Thomas M Green,et al.  A public genome-scale lentiviral expression library of human ORFs , 2011, Nature Methods.

[188]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[189]  A. S. Nateri,et al.  Generating and Utilizing Murine Cas9-Expressing Intestinal Organoids for Large-Scale Knockout Genetic Screening. , 2020, Methods in molecular biology.

[190]  P. Kashyap,et al.  Germ-Free Mice Model for Studying Host-Microbial Interactions. , 2016, Methods in molecular biology.

[191]  M. Dandri,et al.  Experimental models and therapeutic approaches for HBV , 2012, Seminars in Immunopathology.